McClure Matthew W. sold ALGS
February 27, 2024 · Form 4 insider transaction
McClure Matthew W. sold 23,000 shares of Aligos Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
23,000
Price
$0.00
Total value
N/A
InsiderMcClure Matthew W.
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeD: Disposition to the issuer
Transaction dateFebruary 27, 2024
Filing dateFebruary 28, 2024
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 23,000 of the issuer's shares granted to the reporting person on February 4, 2022. In exchange, on February 28, 2024, the reporting person received a replacement option, for 16,428 shares, having an exercise price of $0.96 per share.